The clinical impact of circulating caspase-3 p17 level: a potential new biomarker for myocardial injury and cardiovascular disease.
about
Current and emerging biomarkers of cell death in human disease.Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applicationsThe role of sulfur dioxide in the regulation of mitochondrion-related cardiomyocyte apoptosis in rats with isopropylarterenol-induced myocardial injury
P2860
The clinical impact of circulating caspase-3 p17 level: a potential new biomarker for myocardial injury and cardiovascular disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The clinical impact of circula ...... ry and cardiovascular disease.
@en
The clinical impact of circula ...... ry and cardiovascular disease.
@nl
type
label
The clinical impact of circula ...... ry and cardiovascular disease.
@en
The clinical impact of circula ...... ry and cardiovascular disease.
@nl
prefLabel
The clinical impact of circula ...... ry and cardiovascular disease.
@en
The clinical impact of circula ...... ry and cardiovascular disease.
@nl
P2093
P2860
P356
P1433
P1476
The clinical impact of circula ...... ry and cardiovascular disease.
@en
P2093
Allan S Jaffe
Bruce T Liang
Kanwar P Singh
P2860
P304
P356
10.2217/FCA.11.29
P577
2011-07-01T00:00:00Z